Press releases
Access archived Guidant press releases
Access archived BTG press releases
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 4, 2009
Boston Scientific Corporation today welcomed approval by the U.S. House of Representative's Energy and Commerce Committee of the National Pain Care...
-
Mar 3, 2009
Boston Scientific Corporation today announced the launch of its TAXUS®...
-
Mar 2, 2009
Boston Scientific Corporation today announced that the Company's Board of Directors has elected John E. Sununu...
-
Feb 26, 2009
Boston Scientific Corporation today announced updated financial results for the fourth quarter ended December 31, 2008. Subsequent to the release...
-
Feb 18, 2009
Data show comparable safety for complex patients treated with TAXUS® Express2™ Stents and bypass surgery NATICK, Mass., Feb. 18 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today...
-
Feb 5, 2009
Journal of American College of Cardiology publishes positive ATLAS clinical data NATICK, Mass., Feb. 5 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has submitted...
-
Feb 3, 2009
PLATINUM clinical program to evaluate PROMUS™ Element™ Platinum Chromium Stent NATICK, Mass., Feb. 3 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced the beginning of...
-
Jan 28, 2009
Q4 adjusted results in line with expectations; Company well positioned for 2009 and beyond Company records $2.7 billion goodwill impairment charge NATICK, Mass., Jan. 28 /PRNewswire-FirstCall/ --...
-
Jan 28, 2009
Boston Scientific Corporation announced today that it has received approval from the...
-
Jan 27, 2009
Agreement stops all litigation in interventional cardiology and endovascular repair NATICK, Mass., Jan. 27 /PRNewswire-FirstCall/ -- Boston Scientific Corporation and Medtronic, Inc. today...
-
Jan 20, 2009
Boston Scientific Corporation today announced it has been awarded a contract by the U.S. Department of Veterans Affairs (VA) for a full line of the...
-
Jan 15, 2009
Boston Scientific Corporation today announced a decision by the Court of Appeals for the Federal Circuit. The case involves a Boston Scientific...
-
Jan 13, 2009
Boston Scientific Corporation will webcast its conference call discussing financial results for the fourth quarter and the year ended December 31,...
-
Jan 7, 2009
Boston Scientific Corporation is scheduled to participate in the upcoming JP Morgan Health Care Conference in San Francisco. Jim Tobin, Chief...
-
Jan 6, 2009
Acquisition demonstrates Company's commitment to innovation in drug-eluting stent technology NATICK, Mass., Jan. 6 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it...
-
Dec 18, 2008
Boston Scientific Corporation today announced enrollment of the first patient...
-
Dec 15, 2008First low-profile, pre-mounted stent approved specifically for use in renal arteries
Boston Scientific Corporation today announced that the U.S. Food and Drug Administration (FDA) has approved the Express® SD Renal Monorail®...
-
Nov 24, 2008
Boston Scientific Corporation (NYSE: BSX) is scheduled to participate in the Piper Jaffray Health Care Conference, which is being held December 2 -...
-
Nov 10, 2008New design provides more options for treating patients with complex lesions
Boston Scientific Corporation (NYSE: BSX) today announced that it has received approval from the U.S. Food and Drug Administration to market its...
-
Oct 29, 2008
Boston Scientific Corporation (NYSE: BSX) today welcomed passage of legislation to help active members of the U.S. armed forces and service...
-
Oct 27, 2008Confirms clinical value and cost-effectiveness of spinal cord stimulation
Boston Scientific Corporation (NYSE: BSX) today welcomed an announcement by the U.K.'s National Institute for Health and Clinical Excellence (NICE)...
-
Oct 23, 2008Leading carotid stent in Europe and other international markets now available in the United States
Boston Scientific Corporation (NYSE: BSX) today announced that the U.S. Food and Drug Administration (FDA) has approved its Carotid WALLSTENT®...
-
Oct 21, 2008
Boston Scientific Corporation (NYSE: BSX) today announced financial results for the third quarter ended September 30, 2008, as well as guidance for...
-
Oct 15, 2008Landmark trial provides new insight for physicians
Boston Scientific Corporation (NYSE: BSX) today announced results from an analysis of the HORIZONS AMI trial. The HORIZONS AMI...
-
Oct 15, 2008
Boston Scientific Corporation (NYSE: BSX) today announced positive one-year results from the Intercontinental and European launch...